# Real-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients

> **NCT07296627** · — · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Newly Diagnosed Multiple Myeloma (NDMM)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07296627
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-16
- **Primary completion:** 2027-07-15
- **Final completion:** 2027-11-15
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07296627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07296627, "Real-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07296627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*